According to the most recent analysis by Emergen Research, the size of the worldwide dermatology devices market is anticipated to reach USD 16.13 billion in 2030, growing at a consistent revenue CAGR of 12.7%. The rising frequency of skin problems is one of the main reasons propelling this market’s revenue growth. Skin conditions are widespread throughout the world and have a significant impact on public health in both developed and underdeveloped nations. The most common lesion diagnosed is acne vulgaris, which affects more than 80% of people worldwide at some point in their life and 85% of teenagers in wealthy nations.
Due to the nearly complete suspension of non-COVID-19 related procedures, limited production activities, and interruption in the supply chain, the market saw short-term negative growth. The market has, nevertheless, experienced a V-shaped recovery. The number of dermatological devices is starting to return to pre-pandemic levels with the successful introduction of vaccines in every region. Due to the backlog from 2020 and growing consumer interest in and awareness of dermatological procedures, the market had significant demand in 2021. The market has recently experienced a lot of volatility.
To Obtain All-Inclusive Information On Forecast Analysis Of Global Market, Request A PDF Brochure Here @ https://www.emergenresearch.com/industry-report/dermatology-devices-market
The market for treatment devices, which accounted for over 79% of all sales in 2021, is also predicted to grow at the quickest rate (CAGR) during the projected period. This is primarily because dermatology treatments have numerous applications. The segment growth is also attributed to the introduction of novel technologies in the laser device category. Because fewer people are aware of numerous novel equipment, diagnostic devices have a small market share. However, segment expansion is predicted to be fueled in the future by the rising incidence of skin cancer.
Some Significant Report Highlights
On July 25, 2022, STRATA Skin Sciences, Inc., a healthcare technology company specialising in the development, marketing, and commercialization of cutting-edge products for the treatment of dermatologic conditions, launched TheraClearX in the United States. TheraClearX is a non-invasive, in-office acne treatment that targets the underlying causes of mild to moderate acne, such as comedonal, pustular, and inflammatory acne vulgaris.
Due to the accessibility of several dermatological treatment options and the advent of cutting-edge laser device technologies, the treatment devices category is anticipated to have the highest revenue share over the projection period. For instance, on August 17, 2020, Lumenis Ltd., the leading provider of energy-based medical devices for ophthalmic, surgical, and cosmetic applications, introduced the NuEra Tight. The development of individualised non-invasive RF body treatments using this technology, which are specifically catered to the needs of each patient, is assisting in the expansion of the market’s revenue.
Throughout the projection period, the diagnostic devices segment is anticipated to post a consistent CAGR. It is further divided into diagnoses for skin cancer and other conditions. The sub-segment of skin cancer diagnosis has the highest revenue share due to the rise in skin cancer prevalence. Additionally, the advancement of skin cancer diagnostics through fresh research and development is boosting market revenue. For instance, basal and squamous cell carcinomas are diagnosed in around 3.3 million Americans each year. Researchers at the Huntsman Cancer Institute (HCI) and the University of Utah developed a device called URSKIN that uses non-visual electrical impedance measurements to take advantage of changes in the electrical characteristics of skin that take place during cancer cell proliferation (EID).
View the Full Report Description, the Research Methodology, the Content Table, and the Infographics @ https://www.emergenresearch.com/industry-report/dermatology-devices-market
Emergen Research has segmented the global dermatology devices market on the basis of product, application, end-use, and region:
- Product Outlook (Revenue, USD Billion; 2019–2030)
- Diagnostic Devices
- Treatment Devices
- Application Outlook (Revenue, USD Billion; 2019–2030)
- Diagnostic Devices
- Treatment Devices
- End-Use Outlook (Revenue, USD Billion; 2019–2030)
- Regional Outlook (Revenue, USD Billion; 2019-2030)
- North America
- Rest of Europe
- Asia Pacific
- South Korea
- Rest of APAC
- Latin America
- Rest of LATAM
- Middle East & Africa
- Saudi Arabia
- South Africa
- Rest of MEA
- North America
Emergen Research Has a Limited-Time Discount Available (Grab a Copy at Discounted Price Now) @ https://www.emergenresearch.com/request-discount/1462
View Additional Reports by Emergen Research:
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
Visit for More Insights: https://www.emergenresearch.com/insights